Plain-English translation of NCT06200207 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This research study is testing a new medication called to see if it can help people with heart failure who also have signs of inflammation in their bodies. Half of the participants will receive the medication, and half will receive a placebo (a shot that looks identical but contains no medicine). The study will last up to 16 months, and researchers will measure how the medication affects heart failure symptoms and physical ability to walk and exercise.
Many people with heart failure have persistent inflammation in their bodies, which may make their symptoms worse and limit their ability to be active. Doctors want to know whether this new treatment can reduce inflammation and help people feel better and be more physically active.
If you join this study, you will receive either the new medication or a placebo as a shot under your skin once a month for 12 months, in addition to your regular heart failure medicines. You will visit the study clinic regularly so doctors can check your blood pressure, heart rate, and blood work, and ask you questions about your symptoms and how well you can exercise. The entire study lasts up to 16 months from start to finish.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States